Does Rallies show Form 4 insider transactions for BOLD?

Yes. Rallies tracks BOLD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is BOLD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BOLD. It does not provide personalized investment advice.

BOLD (Boundless Bio, Inc. Common Stock) Stock Analysis - Insider Trades

Boundless Bio, Inc. Common Stock (BOLD) is a publicly traded Healthcare sector company. As of May 21, 2026, BOLD trades at $1.42 with a market cap of $31.90M and a P/E ratio of -0.55. BOLD moved +0.00% today. Year to date, BOLD is +20.34%; over the trailing twelve months it is -14.46%. Its 52-week range spans $0.96 to $3.75. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BOLD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BOLD stock inside the company?

Recent BOLD insider activity includes Burow Kristina bought 66.67K, Burow Kristina bought 133.33K, CRANDELL KEITH bought 66.67K, CRANDELL KEITH bought 133.33K, and ARCH Venture Fund IX, L.P. bought 66.67K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BOLD Key Metrics

Key financial metrics for BOLD
Metric	Value
Price	$1.42
Market Cap	$31.90M
P/E Ratio	-0.55
EPS	$-2.60
Dividend Yield	0.00%
52-Week High	$3.75
52-Week Low	$0.96
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-58.20M
Gross Margin	0.00%

Recent BOLD Insider Trades

Burow Kristina bought 66.67K (~$1.07M) on Apr 2, 2024.
Burow Kristina bought 133.33K (~$2.13M) on Apr 2, 2024.
CRANDELL KEITH bought 66.67K (~$1.07M) on Apr 2, 2024.
CRANDELL KEITH bought 133.33K (~$2.13M) on Apr 2, 2024.
ARCH Venture Fund IX, L.P. bought 66.67K (~$1.07M) on Apr 2, 2024.

Latest BOLD News

Boundless Bio Secures FDA IND for BBI-940, Opens KOMODO-1 Trial with $107.6M Runway — Mar 9, 2026
Boundless Bio Upgraded to Zacks Rank #2 After 34.5% EPS Estimate Surge — Feb 13, 2026

BOLD Analyst Consensus

1 analysts cover BOLD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Common questions about BOLD

Who is trading BOLD stock inside the company?: Recent BOLD insider activity includes Burow Kristina bought 66.67K, Burow Kristina bought 133.33K, CRANDELL KEITH bought 66.67K, CRANDELL KEITH bought 133.33K, and ARCH Venture Fund IX, L.P. bought 66.67K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BOLD?: Yes. Rallies tracks BOLD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BOLD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BOLD. It does not provide personalized investment advice.